NAMI Pharma Marketing Blog Grassley
View PDF of blog article here
Similar Posts
Top SFBC officials Quit Amid Senate Inquiry Clinical Trials_ Bloomberg News
In its continuing coverage of corrupt clinical drug trial practices, Bloomberg News reports that all three founders of SFBC International, one of the largest clinical trial business operations that had failed to even screen human subjects for turberculosis, and threatened others with deportation if they refused to become guinea pigs, quit after the Senate Finance committee began investigating drug trial safety issues:
Parity Likely to Increase Wholesale Sedation of Children
"For her last month of life, Kifuji overall prescribed 835 pills to Rebecca….If what Dr. Kifuji did in this case is the acceptable standard of care for children in Massachusetts, then there is something very wrong in this state."
Staff Survey Confirms FDA Officials Tamper with Science_ Grassley Seeks Investigation of FDA
Bloomberg News reports (below) that Senator Charles Grassley has asked the Inspector General to investigate collusion between FDA officials and Merck. Citing handwritten notes prepared by a Merck executive document a meeting with FDA division director, Brian Harvey, suggesting a joint effort "to get the message out" to discredit Dr….
FDA Squelches an Article Raising Doubts on Safety Of Device to Repair Artery – WSJ
FDA Squelches an Article Raising Doubts on Safety Of Device to Repair Artery – WSJ Fri, 9 Jul 2004 A front page article in The Wall Street Journal exposes another case of safety data suppression by the FDA. The case involves a device to repair the heart artery which FDA’s…
FDA-Encourages Medical Device Hucksterism: Surgical Sinus Treatment_NY
"There is virtually no scientific evidence that the procedure, which involves inflating a small balloon in the sinus cavity, actually works."
Glaxo Pricing Under DOJ investigation / GAO Report Says Medicaid Overpays for Drugs
Glaxo Pricing Under DOJ investigation / GAO Report Says Medicaid Overpays for Drugs Wed, 9 Mar 2005 Reuters reports that GlaxoSmithKline is under investigation by the Department of Justice concerning Medicaid drug pricing. The skyrocketing cost of drugs is depleting Medicaid, the nation’s largest health insturance program paid for by…